Audit 412811

FY End
2025-12-31
Total Expended
$153.15M
Findings
0
Programs
125
Year: 2025 Accepted: 2026-09-29

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
21.027 COVID-19 - Coronavirus State Fiscal Recovery Fund $51.59M Yes 0
84.268 Federal Direct Student Loans (Direct Loan) - Hackensack Meridian School of Medicine $28.67M Yes 0
21.027 COVID-19 - Coronavirus State Fiscal Recovery Fund Project 2024 $17.26M Yes 0
93.855 COVID-19 - Metropolitan AntiViral Drug Accelerator $12.25M Yes 0
93.310 Enriching ECHO Cohorts with High-Risk Pregnancies and Children with Disabilities (Enriching ECHO) $4.40M Yes 0
93.378 Integrated Care for Kids (InCK) $2.72M Yes 0
84.181 Services: Early Intervention System, Special Education Grants for Infants And Families $2.47M Yes 0
93.855 Center for Accelerated Development or Drug Candidates Targeting High Threat Bacterial Infections $1.95M Yes 0
84.268 Federal Direct Student Loans (Direct Loan) - JFK Muhlenberg Schools $1.64M Yes 0
93.855 Celiac and Inflammatory Bowel Disease: Functional Post-GWAS Approach $978,594 Yes 0
97.036 COVID-19 - Federal Emergency Management Agency Disaster Relief Fund $911,884 Yes 0
93.855 Tissue Specific Immunity to Fungal Infections $887,340 Yes 0
93.855 Discovery of Novel Lead-Target Pairs and Identification of All-Oral Bactericidal Drug Regimens for Mycobacterium Abscessus Lung Disease $885,126 Yes 0
93.855 Critical Factors Influencing Echinocandin Resistance in Candida Glabrata $873,463 Yes 0
93.855 Harnessing B Cells for TB Vaccine Development to Improve Therapy of TB and TB-HIV Coinfection $862,299 Yes 0
93.396 Identifying and Characterizing Functional Noncoding Mutations in Multiple Myeloma $816,322 Yes 0
93.855 Center to Develop Therapeutic Countermeasures to High-Threat Bacterial Agents $812,413 Yes 0
11.617 DNA Research Sequence Project $787,661 Yes 0
93.396 ID3 Regulation of Tissue-Infiltrating T Cells Mediating Graft-Versus-Host Disease and Leukemia Rejection $732,264 Yes 0
93.855 Optimization of Rifamycins to Overcome Intrinsic Resistance of Nontuberculous Mycobacteria to Improve Treatment of NTM Lung Disease $714,876 Yes 0
93.393 Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge $684,265 Yes 0
93.855 Shorter and More Effective Oral Regimens for M. Abscessus Pulmonary Disease $616,338 Yes 0
93.855 Preclinical Design and Clinical Translation of TB Regimens (PReDisTR) Consortium $554,853 Yes 0
84.063 Federal Pell Grant Program - JFK Muhlenberg School $533,265 Yes 0
93.396 Nuclear Envelope and Predisposition to Hepatic Neoplasia $508,167 Yes 0
93.396 Harnessing the Thymus for Long-term Tumor Control with Hematopoietic Stem Cell-Derived Naïve CAR T Cells $499,283 Yes 0
93.855 Regulation of T Cell Exhaustion via 3D Chromatin Architecture $483,635 Yes 0
93.243 HMH Youth and Family TREE Program $477,034 Yes 0
21.027 Community-Based Violence Intervention Program $460,554 Yes 0
93.243 I.C.A.R.E. - Integrated Care for Addiction Recovery Expansion $451,576 Yes 0
93.855 HX NIH CTCF In CD8 Tcell $435,252 Yes 0
93.855 Translational Approaches to Improve Understanding and Outcome in Tuberculous Meningitis $427,877 Yes 0
93.855 Transmission Aerobiology of M. Tuberculosis: Genes and Metabolic Pathways that Sustain Mtb Across an Evolutionary Bottleneck $420,366 Yes 0
12.420 Mechanisms of Impaired Swallowing, Speech, and Voice in Parkinson's Disease $414,166 Yes 0
93.917 HIV Care Formula Grants - Ryan White Part B $394,841 Yes 0
93.855 Determinants of TB Control, Relapse and Reinfection $391,770 Yes 0
93.396 Study of the IL-33-Driven Immune Cell Organization Underpinning Responses to Immune Checkpoint Blockade Cancer Therapy $387,998 Yes 0
93.855 TLE Transcription Cofactors in Anti-Viral and Anti-Tumor Immunity $386,814 Yes 0
93.397 Georgetown University Lombardi Comprehensive Cancer Center Support Grant $327,074 Yes 0
93.855 Dissecting the Molecular Targets to Overcome Beta-Lactam Resistance in M. Abscessus Complex $312,460 Yes 0
93.395 Mosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English and Spanish-Speaking Stem Cell Transplant Recipients $312,177 Yes 0
93.855 C25-Modified Rifabutin Analogs as a Novel Medicinal Chemistry Strategy to Overcome Drug-Resistant Tuberculosis $272,831 Yes 0
93.855 Antibacterial Resistance Leadership Group (ARLG) $268,151 Yes 0
12.420 Therapeutic Implications of TNBC-Specific ETV6 Rearrangements: Chemoresistance and Immune Evasion $249,732 Yes 0
16.045 Project Heal: Expansion of Community-Based Violence Intervention & Prevention Initiatives $243,167 Yes 0
93.855 Dissecting the Host-Plasmid Interplay to Unravel the Spread of ESBL-Producing K. Pneumoniae $236,725 Yes 0
93.914 HIV Emergency Relief Project Grants $234,492 Yes 0
93.855 Immunometabolic Regulations of Pulmonary TB Pathogenesis by Adipose Tissue $230,827 Yes 0
93.924 Ryan White HIV/AIDS Dental Reimbursements $214,575 Yes 0
93.398 Cancer Misinformation and Use of Complementary and Alternative Therapy (CAM) Among Patients with Cancer $201,386 Yes 0
93.397 Epigenetic Therapies - New Approaches, Project 1 $191,821 Yes 0
93.855 Effects of Antifungal Drug Treatment and Immune Dysfunction on the Evolutionary Dynamics of Gut-Colonizing Candida Glabrata $186,463 Yes 0
93.870 New Jersey Home Visiting Initiative: Parents as Teachers $169,211 Yes 0
93.243 Hackensack Meridian Carrier Clinic Mental Health Awareness in Identifying Disturbances in Emotions Program (AIDE) $168,609 Yes 0
93.855 Tcf1 Programs Cd8 T Cell Responses to Enhance Viral and Cancer Immunity $165,821 Yes 0
93.839 DOT1L, Reconstitution of Plasmacytoid Dendritic Cells and Alloimmunity $160,498 Yes 0
93.590 Community Prevention Direct Service $154,504 Yes 0
93.855 Accelerator for the Rapid Development of Countermeasures Targeting Drug Resistant Fungal Pathogens $153,921 Yes 0
97.067 FFY22 Urban Area Security Initiative (UASI-Local Share) $149,914 Yes 0
93.393 Dissemination of a Breast Reconstruction Decision Tool Through Social Media and Online Communities $148,686 Yes 0
93.853 Neutrophil Extracellular Traps and Associated Pathogenesis in TBI: A Novel Peptide Therapeutic Strategy $145,728 Yes 0
93.307 Activatexto: Advancing Smoking Cessation and Physical Activity Among Latinos $144,317 Yes 0
93.398 Experimental Evolution of Pancreatic Cancer $133,343 Yes 0
93.853 Comparing Treatment Approaches to Promote Inpatient Rehabilitation Effectiveness for Traumatic Brain Injury (CARE 4 TBI) $127,806 Yes 0
12.420 Role of Core-Binding Factor Rearrangements in Triple-Negative Breast Cancer Progression and Immune Evasion $126,085 Yes 0
93.393 Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening $124,570 Yes 0
93.493 Community Project Funding/Congressionally Directed Spending ‐ Construction $115,404 Yes 0
93.914 Ryan White $106,382 Yes 0
93.398 Elucidating the Role of SMAD4 in Colorectal Cancer $106,048 Yes 0
97.067 FFY23 Urban Area Security Initiative (UASI-Local Share) $105,452 Yes 0
93.393 Population-Based Assessment of Patient-Reported Outcomes In Adults Living With Metastatic Colorectal Cancer $101,623 Yes 0
93.846 Natural History and Validation of Surrogate Biomarkers and Patient-Reported Outcomes for SJIA-LD $91,863 Yes 0
93.110 Pediatric Mental Health Care Access Program 2025 $90,767 Yes 0
10.331 Hackensack Meridian Health Fresh Match Initiative (HMHFM) $88,507 Yes 0
93.395 Study of Interleukin 33 as a New Immunotherapy of Lung Cancer $83,953 Yes 0
93.398 Optimizing Adherence to Lung Cancer Screening: Applying Theory and Implementation Science to Participant Engagement $78,795 Yes 0
93.398 Leveraging Behavioral Science to Improve Patient Understanding of Advanced Cancer $74,146 Yes 0
93.914 Ryan White Services for People Living with HIV $72,528 Yes 0
93.838 COVID-19 - CLOCK (Collaborative Long-Term Study of Outcomes of COVID-19 In Kids) Consortium for PASC Phase II RECOVER Pediatric Cohort $71,013 Yes 0
93.855 Serine/Threonine Kinase Signaling in Beta-Lactam Resistance of Staphylococcus Aureus $70,800 Yes 0
93.855 A Preclinical Program for Targeting Mycobacterium Tuberculosis KasA $66,780 Yes 0
93.855 Modulating Costimulation Pathways to Improve Follicular Helper T Cell and Antibody Responses $64,653 Yes 0
12.420 Building Emotional Self-Awareness $63,002 Yes 0
93.855 Preclinical Development of LCTG-001, a Human Secretory IgA Replacement Therapy for CVID Patients $62,412 Yes 0
93.732 Addiction Medicine Fellowship $59,410 Yes 0
93.839 Leveraging HSF1 Attenuation to Transform Clonal Hematopoiesis into Beneficial Hematopoiesis $59,085 Yes 0
12.420 Host-Directed Approaches to Target Granuloma Pathways for Treatment Shortening in Tuberculosis $54,947 Yes 0
93.855 Within-Host Diversity of Gram Negative Bacteria from Bloodstream Infections $52,622 Yes 0
93.837 The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF) $52,003 Yes 0
93.846 Stopping Hydrochloroquine in Elderly Lupus Disease (SHIELD) $49,416 Yes 0
93.393 TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis $48,127 Yes 0
93.855 Unraveling the Spectrum of Intrabacterial Amide Hydrolysis to Develop New Classes of Pyrazinoic Acid Prodrugs Against Pyrazinamide Resistant Mycobacterium Tuberculosis $46,814 Yes 0
93.395 LncRNA EPIC1 Induces Immunotherapy Resistance by Activating EZH2 in Breast Cancer $42,985 Yes 0
93.917 Ryan White Title B $41,685 Yes 0
93.273 Peptide Therapy for Alcohol-Induced CNS Injury $41,416 Yes 0
93.393 Bridging Information Divides and Gaps to Ensure Survivorship $39,394 Yes 0
93.121 Dissecting Cell Composition and Drug Sensitivity in Humanadenoid Cystic Carcinomas (ACCs) $38,316 Yes 0
93.397 Georgetown University Lombardi Cancer Center Support Grant - Immunotherapy for CRC Liver Metastasis $33,300 Yes 0
93.396 Microbial and Host Biomarkers in Colorectal Cancer Oncogenesis $32,048 Yes 0
93.397 Georgetown University Lombardi Comprehensive Cancer Center Support Grant - Novel Pharmacological Approaches to Prevent and Eradicate Liver Metastases in an Aggressive Subtype of CRC $32,000 Yes 0
93.433 The Traumatic Brain Injury Model Systems National Data and Statistical Center $29,400 Yes 0
93.393 Empathic Communication Skills Training to Reduce Lung Cancer Stigma $28,913 Yes 0
93.110 Pediatric Mental Health Care Access Program 2026 $26,244 Yes 0
93.393 Multilevel Interventions to Increase Adherence to Lung Cancer Screening $25,465 Yes 0
93.855 Novel Dual-Stage Antimalarials: Machine Learning Prediction, Validation and Evolution $25,049 Yes 0
93.853 Temple Strategies to Innovate EmeRgENcy Care Clinical Trials Network (Temple-SIREN) $25,000 Yes 0
93.991 Preventative Health and Health Services Block Grant $24,811 Yes 0
84.007 Federal Supplemental Education Opportunity Grants (FSEOG) - JFK Muhlenberg School $24,400 Yes 0
93.898 National Breast and Cervical Early Detection Program $23,773 Yes 0
93.153 Ryan White Part D $23,413 Yes 0
93.397 Epigenetic Therapies - New Approaches, Pathology Core $23,278 Yes 0
93.994 Maternal and Child Health Services Block Grant to the States $22,734 Yes 0
12.420 Engaging Retiring Military Personnel in VA Lung Cancer Screening Through Codesigned Communication Campaign $16,084 Yes 0
93.855 C5a/C5ar1 Signaling in Protective Immunity During Invasive Candidiasis $15,366 Yes 0
93.395 Role of LSD1 in Triple Negative Breast Cancer Development and Therapeutic Response $13,402 Yes 0
93.394 UNCOVER: Underlying Novel Causes of Onset of Very Early Cancer Research $12,486 Yes 0
93.397 Georgetown University Lombardi Cancer Center Support Grant - Improve Efficacy of CAR-T Cells in Treatment of PDAC $11,757 Yes 0
12.420 Leveraging Nationwide Research Infrastructure to Enrich Brain Health After TBI: The ENRICH Brain Health Study $6,900 Yes 0
93.855 Identifying Drug-Resistant Candida Species Using SuperSelective Primer PCR $4,253 Yes 0
93.855 Defining STIM1 Function at the Immunological Synapse $3,824 Yes 0
93.855 Elucidating Mediators Of Genetic Instability In Candida Glabrata $3,725 Yes 0
93.433 Indiana TBI Model System $3,613 Yes 0
93.889 National Bioterrorism Hospital Preparedness Program $3,496 Yes 0
93.866 Use of the KF Modified Story Memory Technique to Improve New Learning and Memory in Individuals with Mild Cognitive Impairment $2,448 Yes 0
93.397 Georgetown University Lombardi Comprehensive Cancer Center Support Grant - Screen Wise: "LungScreenSDM" Conversational Agent for Supporting Shared Decision-Making in Lung Cancer Screening $2,332 Yes 0

Contacts

Name Title Type
LV8GL8MLU9A3 Nora Moustafa Auditee
8483033363 Timothy Weld Auditor
No contacts on file

Notes to SEFA

The accompanying Schedule of Expenditures of Federal Awards (the “Federal Schedule”) presents the activities of the federal financial assistance programs of Hackensack Meridian Health, Inc. and its subsidiaries (the "Network") that have been financed by the U.S. Government. The information in this Federal Schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this Federal Schedule may differ from amounts presented in or used in preparation of the consolidated financial statements. All financial assistance received directly from federal agencies, as well as financial assistance passed through other governmental agencies or nonprofit organizations, are included on the Federal Schedule. Direct and indirect costs are charged to awards in accordance with cost principles contained in the Uniform Guidance, U.S. Office of the Assistant Secretary Comptroller ("OASC"), OASC-3, A Guide for Hopsitals. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. The accompanying Federal Schedule is presented on the accrual basis of accounting. Because the Federal Schedule presents only a selected portion of the activities of the Network, it is not intended to, and does not, present the consolidated financial position, results of operations, and changes in net assets or cash flows of the Network. The Network does not use the 10% - 15% de-minimus indirect cost rate for sponsored programs, as applicable, as described in Section 200.414 of the Uniform Guidance. The Network charges indirect costs to federal awards based on award-specific rates as defined in each grant award. For awards with program names identified as award years 2024 and 2026, only expenses incurred during the year ended December 31, 2025 are reported on the Schedule. These awards have grant periods that do not align with the Network's calendar year end.
Full Assistance Listing Numbers (“ALN”) and pass through award numbers are presented where available and applicable.
The Network is responsible only for the performance of certain administrative duties with respect to the Federal Direct Student Loan Program and, accordingly, the total outstanding loans are not included in the Network’s consolidated financial statements. The Network operates two distinct Schools, the HMSOM and the JFKSON, that participate in the Federal Direct Student Loan Program. Each School possesses its own Employer Identification Number and independently manages its student financial aid regulatory compliance. It is not practical to determine the balance of loans outstanding to students under this program for either School as of December 31, 2025. The Schedule includes loans granted in 2025.
As of December 31, 2025, the Network recorded $912 in obligated FEMA funds under ALN 97.036 as other revenue in the consolidated statements of operations. The claims submitted represented incurred eligible operating expenses attributed to the Network’s response to COVID-19 which were not only expended but also obligated by the federal and state agencies.